IAIM
PCVX icon

International Assets Investment Management’s Vaxcyte PCVX Stock Holding History

International Assets Investment Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$9.23K – 2332
2025
Q4 		$9.23K Buy
+200
New +$8.95K ﹤0.01% 1683

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

International Assets Investment Management's PCVX Position: Q1 2026 in Review

International Assets Investment Management sold out of Vaxcyte (PCVX) in Q1 2026, closing a stake of 200 shares — an estimated $9.23K sold.

International Assets Investment Management first reported a position in PCVX in Q4 2025 and held it in 1 quarter. The position peaked at $9.23K in Q4 2025. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • International Assets Investment Management reported no remaining Vaxcyte position as of Q1 2026 after selling out during the quarter.
  • International Assets Investment Management sold 200 Vaxcyte shares in Q1 2026, an estimated $9.23K.
  • International Assets Investment Management first reported a position in Vaxcyte in Q4 2025 and held it in 1 quarter.
  • International Assets Investment Management's Vaxcyte position peaked at $9.23K in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on International Assets Investment Management's 13F filing for Q1 2026, filed 1 May 2026.